Correlation Between Okta and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Okta and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Okta and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Okta Inc and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Okta and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Okta with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Okta and Conduit Pharmaceuticals.
Diversification Opportunities for Okta and Conduit Pharmaceuticals
0.49 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Okta and Conduit is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Okta Inc and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Okta is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Okta Inc are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Okta i.e., Okta and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Okta and Conduit Pharmaceuticals
Given the investment horizon of 90 days Okta is expected to generate 47.94 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, Okta Inc is 17.39 times less risky than Conduit Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.35 of returns per unit of risk over similar time horizon. If you would invest 1.00 in Conduit Pharmaceuticals on August 27, 2024 and sell it today you would earn a total of 1.14 from holding Conduit Pharmaceuticals or generate 114.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 52.38% |
| Values | Daily Returns |
Okta Inc vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Okta Inc |
| Conduit Pharmaceuticals |
Okta and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Okta and Conduit Pharmaceuticals
The main advantage of trading using opposite Okta and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Okta position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.The idea behind Okta Inc and Conduit Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Conduit Pharmaceuticals vs. Entravision Communications | Conduit Pharmaceuticals vs. WiMi Hologram Cloud | Conduit Pharmaceuticals vs. Dolphin Entertainment | Conduit Pharmaceuticals vs. The Coca Cola |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Commodity Directory Find actively traded commodities issued by global exchanges |